Delwedd Flaen

Ketamine; A better anti-depressant? An animal study evaluating the efficacy of citalopram, ketamine and their combination in animal models of depression

<p>Background: Despite the availability of vast group of drugs, treatment of depression still remains unsatisfactory, largely due to differential efficacy of antidepressants at adequate doses resulting in treatment refractive depression. In addition, serious adverse effects of anti-depressants...

Disgrifiad llawn

Wedi'i Gadw mewn:

Manylion Llyfryddiaeth
Prif Awduron:	Salim Sheikh (Awdur), Pankaj Sonone (Awdur), Veena Verma (Awdur), Chakar Dhar Tripathi (Awdur), Bushra Ahmed Karim (Awdur), Girish Gulab Meshram (Awdur)
Fformat:	Llyfr
Cyhoeddwyd:	Journal of Neurology, Neurological Science and Disorders - Peertechz Publications, 2021-04-06.
Pynciau:	Research Article
Mynediad Ar-lein:	Connect to this object online.
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg

Comparative evaluation of anti-depressant effects of Citalopram, Ketamine and their combination in animal models of depression: A potential anti-depressant?
gan: Salim Sheikh, et al.
Cyhoeddwyd: (2021)

An experimental study targeting N-methyl-D-aspartate receptor in depression; beyond ketamine
gan: Salim Sheikh, et al.
Cyhoeddwyd: (2020)

Ketamine and depression: a narrative review
gan: Corriger A, et al.
Cyhoeddwyd: (2019)

Ketamine for bipolar depression: an updated systematic review
gan: Farhan Fancy, et al.
Cyhoeddwyd: (2023)

Safety of Repeated Administration of Parenteral Ketamine for Depression
gan: David Feifel, et al.
Cyhoeddwyd: (2020)

Magnesium in Ketamine Administration in Treatment-Resistant Depression
gan: Natalia Górska, et al.
Cyhoeddwyd: (2021)

Variability in the serum and tissue concentrations of pre-incisional ceftriaxone for surgery in paediatric population and outcome of surgical-site infections; An open labelled, prospective, non-randomized, analytical study
gan: Salim Sheikh, et al.
Cyhoeddwyd: (2022)

The Possible Application of Ketamine in the Treatment of Depression in Alzheimer's Disease
gan: Islam Mohammad Shehata, et al.
Cyhoeddwyd: (2022)

The effectiveness of ketamine in medication of treatment-resistant depression - review
gan: Patrycja Brzozowska, et al.
Cyhoeddwyd: (2024)

Th17 Cells in Depression: Are They Crucial for the Antidepressant Effect of Ketamine?
gan: Meiying Cui, et al.
Cyhoeddwyd: (2021)

Ketamine and the Disinhibition Hypothesis: Neurotrophic Factor-Mediated Treatment of Depression
gan: Philip Borsellino, et al.
Cyhoeddwyd: (2023)

Comparison of effects of ketamine, ketamine-dexmedetomidine and ketamine-midazolam on dressing changes of burn patients
gan: Murat Gündüz, et al.
Cyhoeddwyd: (2011)

Association of plasma VEGF levels and the antidepressant effects of ketamine in patients with depression
gan: Wei Zheng, et al.
Cyhoeddwyd: (2021)

Efficacy of different doses of ketamine as a bolus in major depressive disorder
gan: Farzan Kheirkhah, et al.
Cyhoeddwyd: (2018)

Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review
gan: Aleksander Kwaśny, et al.
Cyhoeddwyd: (2023)

Role of the Pharmacist in Managing Treatment-Resistant Depression: A Focus on Ketamine
gan: Linda Xing Yu Liu, et al.
Cyhoeddwyd: (2021)

Residual Depressive Symptoms in Treatment-Resistant Bipolar Depression Following Short-Term Ketamine Administration
gan: Michał Pastuszak, et al.
Cyhoeddwyd: (2024)

Use of ketamine for depression and suicidality in cancer and terminal patients: Review of current data
gan: Aderonke Oyetunji, et al.
Cyhoeddwyd: (2023)

Mechanisms of the Rapid Effects of Ketamine on Depression and Sleep Disturbances: A Narrative Review
gan: Bijia Song, et al.
Cyhoeddwyd: (2021)

Anti-inflammatory effects of ketamine in the treatment-resistant depression: a narrative review
gan: Marta Elżbieta Jóźwiak-Bębenista, et al.
Cyhoeddwyd: (2024)

Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report
gan: Boney Joseph, et al.
Cyhoeddwyd: (2023)

Basic aspects of ketamine therapy for treatment-resistant depression - a review paper
gan: Weronika Szafrańska, et al.
Cyhoeddwyd: (2024)

Safety and Efficacy of Ketamine Versus Ketamine-Fentanyl-Dexmedetomidine Combination for Anesthesia and Analgesia in Rats
gan: Chunzhu Li, et al.
Cyhoeddwyd: (2019)

Pharmacological Mechanism of Ketamine in Suicidal Behavior Based on Animal Models of Aggressiveness and Impulsivity: A Narrative Review
gan: Thi Mai Loan Nguyen, et al.
Cyhoeddwyd: (2023)

Apnea during slow sub-anaesthetic infusion of intravenous ketamine for treatment-resistant depression
gan: Marcos Gómez-Revuelta, et al.
Cyhoeddwyd: (2020)

The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant Depression
gan: Brittany O'Brien, et al.
Cyhoeddwyd: (2019)

Unique Effects of (R)-Ketamine Compared to (S)-Ketamine on EEG Theta Power in Rats
gan: Dóra Pothorszki, et al.
Cyhoeddwyd: (2024)

Effect of Acute Ketamine Treatment on Sympathetic Regulation Indexed by Electrodermal Activity in Adolescent Major Depression
gan: Veronika Kovacova, et al.
Cyhoeddwyd: (2024)

Retracing our steps to understand ketamine in depression: A focused review of hypothesized mechanisms of action
gan: Madison N. Irwin, PharmD, et al.
Cyhoeddwyd: (2021)

Combining ketamine with astrocytic inhibitor as a potential analgesic strategy for neuropathic pain. ketamine, astrocytic inhibitor and pain
gan: Mei Xiao-Peng, et al.
Cyhoeddwyd: (2010)

P53 expression in ischemic rat models after the administration of ketamine and ketamine-xylazine
gan: Ety Sari Handayani, et al.
Cyhoeddwyd: (2020)

Ketamine Revisited New Insights into NMDA Inhibitors
Cyhoeddwyd: (2022)

Animal models of depression
gan: T. L. Garibova, et al.
Cyhoeddwyd: (2017)

Ketamine and Active Ketamine Metabolites Regulate STAT3 and the Type I Interferon Pathway in Human Microglia: Molecular Mechanisms Linked to the Antidepressant Effects of Ketamine
gan: Ming-Fen Ho, et al.
Cyhoeddwyd: (2019)

The Combination of Propofol and Ketamine Does Not Enhance Clinical Responses to Electroconvulsive Therapy in Major Depression-The Results From the KEOpS Study
gan: Jerome Brunelin, et al.
Cyhoeddwyd: (2020)

Using Oral and Intranasal Dosage Forms of Ketamine for Managing Treatment-Resistant Depression: A Review of the Literature
gan: Patrick Arthur Twohig, et al.
Cyhoeddwyd: (2016)

Ketamine Alleviates Postoperative Depression-Like Symptoms in Susceptible Mice: The Role of BDNF-TrkB Signaling
gan: Shan Li, et al.
Cyhoeddwyd: (2020)

Association between plasma levels of BDNF and the antisuicidal effects of repeated ketamine infusions in depression with suicidal ideation
gan: Wei Zheng, et al.
Cyhoeddwyd: (2020)

A Systematic Review on Ketamine and Esketamine for Treatment-Resistant Depression and Suicidality in Adolescents: A New Hope?
gan: Simone Pardossi, et al.
Cyhoeddwyd: (2024)

The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review
gan: Ludivine Boudieu, et al.
Cyhoeddwyd: (2023)